AngioDynamics, Inc. ANGO
$15.85
+1.21%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | FORM 4 | 2026-07-31 | View → |
| 4 | FORM 4 | 2026-07-24 | View → |
| 4 | FORM 4 | 2026-07-24 | View → |
| 4 | FORM 4 | 2026-07-24 | View → |
| 4 | FORM 4 | 2026-07-24 | View → |
| 4 | FORM 4 | 2026-07-24 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-22 | View → |
| 4 | FORM 4 | 2026-07-21 | View → |
| 4 | FORM 4 | 2026-07-21 | View → |
| 4 | FORM 4 | 2026-07-21 | View → |
| 4 | FORM 4 | 2026-07-21 | View → |
| 4 | FORM 4 | 2026-07-21 | View → |
| 4 | FORM 4 | 2026-07-21 | View → |
| 10-K | 10-K | 2026-07-14 | View → |
| 8-K | 8-K | 2026-07-14 | View → |
| 8-K | 8-K | 2026-04-23 | View → |
| 10-Q | 10-Q | 2026-04-02 | View → |
| 8-K | 8-K | 2026-04-02 | View → |
| 8-K | 8-K | 2026-02-03 | View → |
| 8-K | 8-K | 2026-01-14 | View → |
| 10-Q | 10-Q | 2026-01-06 | View → |
| 8-K | 8-K | 2026-01-06 | View → |
| 8-K | 8-K | 2025-11-12 | View → |
| 4 | FORM 4 | 2025-10-22 | View → |
| 4 | FORM 4 | 2025-10-14 | View → |
| 4 | FORM 4 | 2025-10-09 | View → |
| 10-Q | 10-Q | 2025-10-02 | View → |
| 8-K | 8-K | 2025-10-02 | View → |
| DEF 14A | DEF 14A | 2025-09-25 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $15.85
- Market Cap
- $650.99 million
- 52-Week Range
- $8.36 – $16.11
- Average Volume
- 558K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
